Association between inflammatory cytokines in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

Association between inflammatory cytokines in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

PurposeTo investigate the associations between cytokine levels in the aqueous humor (AH) and hyperreflective foci (HF) on spectral-domain optical coherence tomography (SD-OCT) in neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV).MethodsThe prospective st...

Full description

Bibliographic Details
Main Authors:	Jianbo Mao, Nuo Chen, Shian Zhang, Yuyan Fang, Zicheng Zheng, Sulan Wu, Xin Ye, Yijing Chen, Yiqi Chen, Lijun Shen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Medicine
Subjects:	aqueous humor cytokine hyperreflective foci neovascular age-related macular degeneration polypoidal choroidal vasculopathy spectral-domain optical coherence tomography
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.973025/full

Similar Items

Retinal hyperreflective foci in Fabry disease
by: Yevgeniya Atiskova, et al.
Published: (2019-12-01)

Association of Monocyte to High-Density Lipoprotein Cholesterol Ratio with Hyperreflective Foci in Patients with Diabetic Macular Edema
by: Ümit Çallı, et al.
Published: (2023-09-01)

Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China
by: Shulin Liu, et al.
Published: (2019-07-01)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
by: Kapil G. Kapoor, et al.
Published: (2015-12-01)

Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion
by: Bin Mo, et al.
Published: (2017-04-01)

Characteristics of Fundus Autofluorescence in Active Polypoidal Choroidal Vasculopathy
by: Zafer Öztaş, et al.
Published: (2016-08-01)

Hyperreflective material in patients with non-neovascular pachychoroid disease
by: Maiko Maruyama-Inoue, et al.
Published: (2023-06-01)

OCT Hyperreflective Retinal Foci in Diabetic Retinopathy: A Semi-Automatic Detection Comparative Study
by: Edoardo Midena, et al.
Published: (2021-04-01)

Treatment Outcomes in Patients with Polypoidal Choroidal Vasculopathy
by: Mümin Hocaoğlu, et al.
Published: (2016-01-01)

Progress in treatment of submacular hemorrhage due to polypoid choroidal vasculopathy
by: Shuang Zhang, et al.
Published: (2019-06-01)

Different Morphology of Branching Neovascular Network in Polypoidal Choroidal Vasculopathy: A Swept-Source Optical Coherence Tomography Angiography Study
by: Lulu Chen, et al.
Published: (2023-01-01)

Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
by: Xiaoya Gu, et al.
Published: (2019-07-01)

Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
by: Yumiko Nakano, et al.
Published: (2018-01-01)

Observation of a pulsatile choroidal vascular lesion in a patient with polypoidal choroid vasculopathy during vitrectomy
by: Ting Zhang, et al.
Published: (2022-06-01)

Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
by: Jingyuan Yang, et al.
Published: (2019-11-01)

Comparison of hyperreflective foci in macular edema secondary to multiple etiologies with spectral-domain optical coherence tomography: An observational study
by: Ruilin Zhu, et al.
Published: (2022-08-01)

Systemic Risk Factors for Vitreous Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy
by: Baoyi Liu, et al.
Published: (2023-08-01)

The Presence of Hyperreflective Foci Reflects Vascular, Morphologic and Metabolic Alterations in Retinitis Pigmentosa
by: Clemens Diem, et al.
Published: (2022-11-01)

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy
by: Yoshiko Fukuda, et al.
Published: (2021-09-01)

Effect of vitrectomy with intravitreal Conbercept injection for polypoidal choroidal vasculopathy associated with vitreous hemorrhage
by: Jian Shen, et al.
Published: (2018-09-01)

Photodynamic Therapy and Bevacizumab Combination for Polypoidal Choroidal Vasculopathy Refractory to Intravitreal Ranibizumab
by: Zeynep Alkin, et al.
Published: (2016-12-01)

Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience
by: Aditya Bansal, et al.
Published: (2017-01-01)

Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes – A multicenter retrospective study
by: DebdulalChakraborty, et al.
Published: (2022-01-01)

Choriocapillaris flow deficits in polypoidal choroidal vasculopathy using swept source optical coherence tomography angiography
by: Maanasi Mahalingam, et al.
Published: (2022-01-01)

Evolution of Polypoidal Lesions after Treatment of Polypoidal Choroidal Vasculopathy
by: Colin S. Tan, MMed (Ophth), FRCOphth, et al.
Published: (2022-03-01)

Automated evaluation of retinal hyperreflective foci changes in diabetic macular edema patients before and after intravitreal injection
by: Xingguo Wang, et al.
Published: (2023-10-01)

Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema
by: Shiyue Qin, et al.
Published: (2021-12-01)

Effect of Epiretinal Membrane Peeling on Intravitreal Aflibercept Therapy Response for Polypoidal Choroidal Vasculopathy: A Case Report
by: Aslı Kırmacı, et al.
Published: (2018-04-01)

AFLIBERCEPT IN TREATMENT OF RESISTANT POLYPOID CHOROIDAL VASCULOPATHY: SHORT-TERM RESULTS
by: E. K. Pedanova, et al.
Published: (2017-12-01)

Activation of quiescent polypoidal choroidal vasculopathy after membrane peeling vitrectomy for epiretinal membrane: a case report
by: Yuelin Wang, et al.
Published: (2021-09-01)

Polypoidal choroidal vasculopathy: An update on current management and review of literature
by: Amit Harishchandra Palkar, et al.
Published: (2019-01-01)

Comparison of cytokine levels in the aqueous humor of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration patients
by: Huiying Zhou, et al.
Published: (2020-01-01)

One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
by: Marta Medina-Baena, et al.
Published: (2018-03-01)

Polypoidal Choroidal Vasculopathy: An Update on Therapeutic Approaches
by: Raymond L.M. Wong, et al.
Published: (2013-01-01)

Choroidal nevus and polypoidal vasculopathy: case series
by: Karlos Ítalo S. Viana, et al.
Published: (2020-06-01)

A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patients
by: Dimitrios A Karagiannis, et al.
Published: (2009-06-01)

Short-Term Outcomes of Switching to Ranibizumab in Polypoidal Choroidal Vasculopathy Resistant to Aflibercept Therapy
by: Young-Joon Jeon, et al.
Published: (2021-12-01)

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
by: Sumit Randhir Singh, et al.
Published: (2019-01-01)

Effect of intravitreal Conbercept on wet age-related macular degeneration and polypoidal choroidal vasculopathy
by: Ying-Chun Li, et al.
Published: (2015-11-01)

Semi-automated quantification of vitreal hyperreflective foci in SD-OCT and their relevance in patients with peripheral retinal breaks
by: P. Strzalkowski, et al.
Published: (2023-07-01)